vs
Side-by-side financial comparison of READING INTERNATIONAL INC (RDI) and VIEMED HEALTHCARE, INC. (VMD). Click either name above to swap in a different company.
VIEMED HEALTHCARE, INC. is the larger business by last-quarter revenue ($76.2M vs $50.3M, roughly 1.5× READING INTERNATIONAL INC). VIEMED HEALTHCARE, INC. runs the higher net margin — 7.4% vs -5.1%, a 12.5% gap on every dollar of revenue. On growth, VIEMED HEALTHCARE, INC. posted the faster year-over-year revenue change (25.5% vs -14.2%). VIEMED HEALTHCARE, INC. produced more free cash flow last quarter ($9.7M vs $4.1M). Over the past eight quarters, VIEMED HEALTHCARE, INC.'s revenue compounded faster (22.7% CAGR vs 5.6%).
The Reading Company was a Philadelphia-headquartered railroad that provided passenger and freight transport in eastern Pennsylvania and neighboring states from 1924 until its acquisition by Conrail in 1976.
Viemed Healthcare, Inc. is a medical technology firm specializing in respiratory care solutions. It develops, manufactures and distributes portable ventilators, respiratory therapy devices and related support services, catering to acute care, post-acute care and home care segments across North America, Europe and key Asia-Pacific markets for patients with respiratory conditions.
RDI vs VMD — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $50.3M | $76.2M |
| Net Profit | $-2.6M | $5.6M |
| Gross Margin | — | 57.9% |
| Operating Margin | -1.9% | 11.0% |
| Net Margin | -5.1% | 7.4% |
| Revenue YoY | -14.2% | 25.5% |
| Net Profit YoY | -14.5% | 30.7% |
| EPS (diluted) | $-0.11 | $0.14 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $50.3M | $76.2M | ||
| Q3 25 | $52.2M | $71.9M | ||
| Q2 25 | $60.4M | $63.1M | ||
| Q1 25 | $40.2M | $59.1M | ||
| Q4 24 | $58.6M | $60.7M | ||
| Q3 24 | $60.1M | $58.0M | ||
| Q2 24 | $46.8M | $55.0M | ||
| Q1 24 | $45.1M | $50.6M |
| Q4 25 | $-2.6M | $5.6M | ||
| Q3 25 | $-4.2M | $3.5M | ||
| Q2 25 | $-2.7M | $3.2M | ||
| Q1 25 | $-4.8M | $2.6M | ||
| Q4 24 | $-2.2M | $4.3M | ||
| Q3 24 | $-7.0M | $3.9M | ||
| Q2 24 | $-12.8M | $1.5M | ||
| Q1 24 | $-13.2M | $1.6M |
| Q4 25 | — | 57.9% | ||
| Q3 25 | — | 57.5% | ||
| Q2 25 | — | 58.3% | ||
| Q1 25 | — | 56.3% | ||
| Q4 24 | — | 59.5% | ||
| Q3 24 | — | 59.3% | ||
| Q2 24 | — | 59.8% | ||
| Q1 24 | — | 58.9% |
| Q4 25 | -1.9% | 11.0% | ||
| Q3 25 | -0.6% | 7.8% | ||
| Q2 25 | 4.8% | 8.1% | ||
| Q1 25 | -17.2% | 6.5% | ||
| Q4 24 | 2.6% | 10.6% | ||
| Q3 24 | -0.6% | 9.7% | ||
| Q2 24 | -16.4% | 6.6% | ||
| Q1 24 | -16.7% | 4.4% |
| Q4 25 | -5.1% | 7.4% | ||
| Q3 25 | -8.0% | 4.9% | ||
| Q2 25 | -4.4% | 5.0% | ||
| Q1 25 | -11.8% | 4.4% | ||
| Q4 24 | -3.8% | 7.1% | ||
| Q3 24 | -11.7% | 6.7% | ||
| Q2 24 | -27.4% | 2.7% | ||
| Q1 24 | -29.4% | 3.2% |
| Q4 25 | $-0.11 | $0.14 | ||
| Q3 25 | $-0.18 | $0.09 | ||
| Q2 25 | $-0.12 | $0.08 | ||
| Q1 25 | $-0.21 | $0.06 | ||
| Q4 24 | $-0.11 | $0.10 | ||
| Q3 24 | $-0.31 | $0.10 | ||
| Q2 24 | $-0.57 | $0.04 | ||
| Q1 24 | $-0.59 | $0.04 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $10.5M | $13.5M |
| Total DebtLower is stronger | $185.1M | — |
| Stockholders' EquityBook value | $-18.2M | $141.5M |
| Total Assets | $434.9M | $199.2M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $10.5M | $13.5M | ||
| Q3 25 | $8.1M | $11.1M | ||
| Q2 25 | $9.1M | $20.0M | ||
| Q1 25 | $5.9M | $10.2M | ||
| Q4 24 | $12.4M | $17.5M | ||
| Q3 24 | $10.1M | $11.3M | ||
| Q2 24 | $9.3M | $8.8M | ||
| Q1 24 | $7.5M | $7.3M |
| Q4 25 | $185.1M | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $202.7M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $-18.2M | $141.5M | ||
| Q3 25 | $-12.1M | $133.6M | ||
| Q2 25 | $-7.7M | $139.7M | ||
| Q1 25 | $-8.1M | $134.8M | ||
| Q4 24 | $-4.4M | $131.4M | ||
| Q3 24 | $1.6M | $125.0M | ||
| Q2 24 | $6.5M | $119.4M | ||
| Q1 24 | $18.0M | $116.3M |
| Q4 25 | $434.9M | $199.2M | ||
| Q3 25 | $435.2M | $202.4M | ||
| Q2 25 | $438.1M | $184.6M | ||
| Q1 25 | $441.0M | $178.1M | ||
| Q4 24 | $471.0M | $177.1M | ||
| Q3 24 | $495.7M | $169.5M | ||
| Q2 24 | $494.9M | $163.9M | ||
| Q1 24 | $494.9M | $154.9M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $4.3M | $18.4M |
| Free Cash FlowOCF − Capex | $4.1M | $9.7M |
| FCF MarginFCF / Revenue | 8.2% | 12.7% |
| Capex IntensityCapex / Revenue | 0.3% | 11.5% |
| Cash ConversionOCF / Net Profit | — | 3.27× |
| TTM Free Cash FlowTrailing 4 quarters | $-2.9M | $11.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $4.3M | $18.4M | ||
| Q3 25 | $295.0K | $18.4M | ||
| Q2 25 | $1.6M | $12.3M | ||
| Q1 25 | $-7.7M | $2.9M | ||
| Q4 24 | $8.0M | $15.0M | ||
| Q3 24 | $1.3M | $12.7M | ||
| Q2 24 | $-10.4M | $10.2M | ||
| Q1 24 | $-2.8M | $1.2M |
| Q4 25 | $4.1M | $9.7M | ||
| Q3 25 | $-246.0K | $10.7M | ||
| Q2 25 | $1.2M | $4.1M | ||
| Q1 25 | $-8.0M | $-12.6M | ||
| Q4 24 | $7.0M | $3.2M | ||
| Q3 24 | $-1.1M | $1.7M | ||
| Q2 24 | $-10.6M | $1.2M | ||
| Q1 24 | $-4.7M | $-4.8M |
| Q4 25 | 8.2% | 12.7% | ||
| Q3 25 | -0.5% | 14.9% | ||
| Q2 25 | 1.9% | 6.5% | ||
| Q1 25 | -19.8% | -21.4% | ||
| Q4 24 | 12.0% | 5.2% | ||
| Q3 24 | -1.8% | 3.0% | ||
| Q2 24 | -22.7% | 2.3% | ||
| Q1 24 | -10.4% | -9.5% |
| Q4 25 | 0.3% | 11.5% | ||
| Q3 25 | 1.0% | 10.6% | ||
| Q2 25 | 0.6% | 12.9% | ||
| Q1 25 | 0.6% | 26.2% | ||
| Q4 24 | 1.7% | 19.5% | ||
| Q3 24 | 4.0% | 19.0% | ||
| Q2 24 | 0.5% | 16.3% | ||
| Q1 24 | 4.3% | 11.9% |
| Q4 25 | — | 3.27× | ||
| Q3 25 | — | 5.23× | ||
| Q2 25 | — | 3.88× | ||
| Q1 25 | — | 1.09× | ||
| Q4 24 | — | 3.47× | ||
| Q3 24 | — | 3.29× | ||
| Q2 24 | — | 6.94× | ||
| Q1 24 | — | 0.73× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
RDI
| Cinema Exhibition Segment | $46.9M | 93% |
| Real Estate Revenue | $3.4M | 7% |
VMD
Segment breakdown not available.
